Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dogs

J Nutr. 2000 May;130(5):1267-73. doi: 10.1093/jn/130.5.1267.

Abstract

To evaluate the potential of indigestible oligosaccharides (OS) to serve as "dietary fiber-like" ingredients, it is necessary to determine their extent of indigestibility. In vitro fermentation characteristics of two novel OS, alpha-glucooligosaccharides (GOS) and a maltodextrin-like OS (MD), were compared to those of fructooligosaccharides (FOS), gum arabic (GA), guar gum (GG) and guar hydrolysate (GH). Total short-chain fatty acid (SCFA) production (micromol/g dry matter) as a result of MD fermentation was higher initially compared with GA (P<0.01), but GA was more extensively fermented at 24 h (P<0.01). Total SCFA production for GOS was similar to that for FOS, GG, GH and GA. In the second experiment, GOS and MD were added at 6% to an enteral formula control diet (Control) and fed to ileal-cannulated dogs in a 3x3 replicated Latin-square design. Ileal digestibility of glucose was lower (P<0.05) and carbohydrate (CHO) numerically lower (P = 0.08) for both GOS and MD compared with the Control. Total tract digestibility of CHO and glucose was lower only for MD (P<0.01) compared with the Control. Total fecal weights were higher (P<0.01) for both GOS and MD treatments. Fecal concentration of bifidobacteria was numerically increased by GOS and MD supplementation (P = 0.13 and 0.23, respectively). Thus, GOS and MD are indigestible yet fermentable OS, and may act as "dietary fiber-like" ingredients.

MeSH terms

  • Animals
  • Bacteroides / drug effects*
  • Chromatography, High Pressure Liquid
  • Diet*
  • Digestion* / drug effects
  • Dogs
  • Enteral Nutrition
  • Fatty Acids, Volatile / biosynthesis*
  • Feces / microbiology*
  • Female
  • Fermentation
  • Glucose / metabolism
  • Hydrogen-Ion Concentration
  • Intestinal Mucosa / metabolism
  • Intestines / microbiology*
  • Oligosaccharides / administration & dosage
  • Oligosaccharides / pharmacology*
  • Substrate Specificity

Substances

  • Fatty Acids, Volatile
  • Oligosaccharides
  • Glucose